Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation
Clinical trial NCT01237808 · COMPLETED
Trial details
- NCT number
- NCT01237808
- Sponsor
- University of Ulm
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2018-07-13
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.